Stevanato Group S.p.A. Declares Annual Dividend of €0.05 (NYSE:STVN)

Posted by Logan Wallace on Jun 9th, 2026

Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) announced an annual dividend on Friday, April 10th. Stockholders of record on Thursday, June 11th will be paid a dividend of 0.054 per share on Wednesday, July 29th. This represents a dividend yield of 29.0%. The ex-dividend date of this dividend is Thursday, June 11th.

Stevanato Group has a dividend payout ratio of 8.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Stevanato Group to earn $0.80 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 7.5%.

Stevanato Group Trading Up 0.1%

Shares of Stevanato Group stock opened at €18.02 on Tuesday. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €28.00. The stock has a market cap of $5.46 billion, a P/E ratio of 30.54, a P/E/G ratio of 1.70 and a beta of 0.78. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. The business’s 50 day moving average is €16.49 and its 200-day moving average is €17.75.

Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The company had revenue of €273.57 million for the quarter. During the same quarter in the prior year, the company posted $0.10 EPS. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. Equities research analysts predict that Stevanato Group will post 0.68 earnings per share for the current fiscal year.

About Stevanato Group

(Get Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.